首页|氯吡格雷联合阿司匹林治疗老年冠心病的临床疗效分析

氯吡格雷联合阿司匹林治疗老年冠心病的临床疗效分析

Clinical efficacy analysis of clopidogrel combined with aspirin in the treatment of coronary heart disease in the elderly

扫码查看
目的 分析氯吡格雷联合阿司匹林治疗老年冠心病的效果.方法 60 例老年冠心病患者纳入此次研究,随机分为研究组与常规组,每组 30 例.常规组患者实施阿司匹林治疗,研究组患者实施氯吡格雷联合阿司匹林治疗.对比两组治疗效果、炎症指标[白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)以及超敏C反应蛋白(hs-CRP)]、凝血功能[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(Fbg)]、不良反应发生情况.结果 研究组患者治疗总有效率 93.33%显著高于常规组的 73.33%,差异显著(P<0.05).治疗前,两组IL-6、TNF-α、hs-CRP对比差异无统计学意义(P>0.05);治疗后,研究组患者IL-6(34.15±3.14)pg/ml、TNF-α(103.23±18.40)pg/ml、hs-CRP(7.53±1.35)mg/L较常规组的(43.71±3.56)pg/ml、(137.88±20.41)pg/ml、(9.54±1.81)mg/L更优,差异显著(P<0.05).治疗前,两组APTT、PT、Fbg对比差异无统计学意义(P>0.05);治疗后,研究组APTT(33.19±2.03)s、PT(13.14±1.36)s、Fbg(2.12±0.85)g/L均优于常规组的(30.89±3.11)s、(11.58±2.47)s、(3.11±1.02)g/L,差异显著(P<0.05).研究组不良反应发生率 10.00%低于常规组的 33.33%,差异显著(P<0.05).结论 氯吡格雷联合阿司匹林在老年冠心病患者治疗中,其效果十分显著.
Objective To analyze the effect of clopidogrel combined with aspirin in the treatment of coronary heart disease in the elderly.Methods A total of 60 elderly patients with coronary heart disease were included and randomly divided into a study group and a conventional group,with 30 cases in each group.The study group received clopidogrel combined with aspirin treatment,while the conventional group received aspirin treatment.Both groups were compared in terms of treatment effects,inflammatory markers[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)and hypersensitive C-reactive protein(hs-CRP)],coagulation function[prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(Fbg)],and adverse reactions.Results The total effective rate of 93.33%in the study group was significantly higher than 73.33%in the conventional group,and the difference was significant(P<0.05).Before treatment,there was no significant difference in IL-6,TNF-α and hs-CRP between the two groups(P>0.05).After treatment,the study group had IL-6 of(34.15±3.14)pg/ml,TNF-α of(103.23±18.40)pg/ml and hs-CRP of(7.53±1.35)mg/L,which were higher than(43.71±3.56)pg/ml,(137.88±20.41)pg/ml and(9.54±1.81)mg/L in the conventional group,and the difference was significant(P<0.05).Before treatment,there was no significant difference in APTT,PT and Fbg between the two groups(P>0.05).After treatment,the study group had APTT of(33.19±2.03)s,PT of(13.14±1.36)s and Fbg of(2.12±0.85)g/L,which were better than(30.89±3.11)s,(11.58±2.47)s and(3.11±1.02)g/L in the conventional group.The difference was significant(P<0.05).The incidence of adverse reactions in the study group was 10.00%,which was lower than 33.33%in the conventional group,and the difference was significant(P<0.05).Conclusion Clopidogrel combined with aspirin is effective in the treatment of elderly patients with coronary heart disease.

ClopidogrelAspirinCoronary heart disease in the elderlyClinical efficacy

赵中伟

展开 >

276500 山东省日照市莒县人民医院

氯吡格雷 阿司匹林 老年冠心病 临床疗效

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(6)
  • 12